Mortality Risk for Acute Cholangitis (MAC): A risk prediction model for in-hospital mortality in patients with acute cholangitis

BMC Gastroenterology

Volumn 16, Issue 1, 2016, Pages

  Schneider, Jochen ^a   Hapfelmeier, Alexander ^b   Thöres, Sieglinde ^a   Obermeier, Andreas ^a   Schulz, Christoph ^b   Pförringer, Dominik ^a   Nennstiel, Simon ^a   Spinner, Christoph ^a   Schmid, Roland M ^a   Algül, Hana ^a   Huber, Wolfgang ^a   Weber, Andreas ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Bacterial infections; Cholangitis; Gastroenterology

Indexed keywords

C REACTIVE PROTEIN; CATECHOLAMINE; CREATININE;

ACUTE CHOLANGITIS; ADULT; AGE DISTRIBUTION; AGED; AREA UNDER THE CURVE; ARTICLE; CATECHOLAMINE BLOOD LEVEL; CHOLANGITIS; CREATININE BLOOD LEVEL; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; GERMANY; HIGH RISK POPULATION; HUMAN; LEUKOCYTE COUNT; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY; PREDICTION; PREDICTIVE VALUE; RANDOM FOREST; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL PREDICTION; TERTIARY CARE CENTER; VALIDATION STUDY; VERY ELDERLY; ACUTE DISEASE; AGE; HOSPITAL MORTALITY; MIDDLE AGED; PROCEDURES; RISK FACTOR; STATISTICAL MODEL;

ACUTE DISEASE; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; CHOLANGITIS; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84960108669     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/s12876-016-0428-1     Document Type: Article

References (28)

1. Hanau LH, Steigbigel NH. Acute (ascending) cholangitis. Infect Dis Clin North Am. 2000;14(3):521-46.
2. Kinney TP. Management of ascending cholangitis. Gastrointest Endosc Clin N Am. 2007;17(2):289-306, vi.
3. Kiriyama S, Takada T, Strasberg SM, Solomkin JS, Mayumi T, Pitt HA, et al. TG13 guidelines for diagnosis and severity grading of acute cholangitis (with videos). J Hepatobiliary Pancreat Sci. 2013;20(1):24-34.
4. Mosler P. Diagnosis and management of acute cholangitis. Curr Gastroenterol Rep. 2011;13(2):166-72.
5. Kochar R, Banerjee S. Infections of the biliary tract. Gastrointest Endosc Clin N Am. 2013;23(2):199-218.
6. Lee JG. Diagnosis and management of acute cholangitis. Nat Rev Gastroenterol Hepatol. 2009;6(9):533-41.
7. Schonberg MA, Davis RB, McCarthy EP, Marcantonio ER. External validation of an index to predict up to 9-year mortality of community-dwelling adults aged 65 and older. J Am Geriatr Soc. 2011;59(8):1444-51.
8. Schonberg MA, Davis RB, McCarthy EP, Marcantonio ER. Index to predict 5-year mortality of community-dwelling adults aged 65 and older using data from the National Health Interview Survey. J Gen Intern Med. 2009;24(10):1115-22.
9. Fried LP, Kronmal RA, Newman AB, Bild DE, Mittelmark MB, Polak JF, et al. Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study. JAMA. 1998;279(8):585-92.
10. Palmu AA, Saukkoriipi A, Snellman M, Jokinen J, Torkko P, Ziegler T, et al. Incidence and etiology of community-acquired pneumonia in the elderly in a prospective population-based study. Scand J Infect Dis. 2014 Apr;46(4):250-9. doi: 10.3109/00365548.2013.876509. Epub 2014 Jan 29.
11. Venables W. N. RBD. Modern Applied Statitics with S., 4 edn: Springer; Springer, New York 2002.
12. Goeman JJ. L1 penalized estimation in the Cox proportional hazards model. Biom J. 2010;52(1):70-84.
13. Hothorn T, Buhlmann P. Model-based boosting in high dimensions. Bioinformatics. 2006;22(22):2828-9.
14. Hothorn T. HK, Zeileis A. Unbiased recursive partitioning: a conditional inference framework. J Comput Graphical Stat. 2006;15(3):651-74.
15. Hothorn T, Buhlmann P, Dudoit S, Molinaro A, van der Laan MJ. Survival ensembles. Biostatistics. 2006;7(3):355-73.
16. Hapfelmeier AHT, Ulm K, Strobl A. A new variable importance measure for random forests with missing data. Stat Comput. 2014;24(1):21-34.
17. Hapfelmeier AUK. A new variable selection approach using random forests. Comput Stat Data Anal. 2013;60:50-69.
18. Misc Functions of the Department of Statistics. [ http://cran.r-project.org/web/packages/e1071/index.html ].
19. Hastie T FJ, Tibshirani R. The elements of statistical learning, vol. 2. New York: Springer; 2009.
20. Mayumi T, Someya K, Ootubo H, Takama T, Kido T, Kamezaki F, et al. Progression of Tokyo Guidelines and Japanese Guidelines for management of acute cholangitis and cholecystitis. J UOEH. 2013;35(4):249-57.
21. Yokoe M, Takada T, Strasberg SM, Solomkin JS, Mayumi T, Gomi H, et al. New diagnostic criteria and severity assessment of acute cholecystitis in revised Tokyo Guidelines. J Hepatobiliary Pancreat Sci. 2012;19(5):578-85.
22. Jang SE, Park SW, Lee BS, Shin CM, Lee SH, Kim JW, et al. Management for CBD stone-related mild to moderate acute cholangitis: urgent versus elective ERCP. Dig Dis Sci. 2013;58(7):2082-7.
23. Hui CK, Lai KC, Yuen MF, Ng M, Lai CL, Lam SK. Acute cholangitis--predictive factors for emergency ERCP. Aliment Pharmacol Ther. 2001;15(10):1633-7.
24. Salek J, Livote E, Sideridis K, Bank S. Analysis of risk factors predictive of early mortality and urgent ERCP in acute cholangitis. J Clin Gastroenterol. 2009;43(2):171-5.
25. Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58(5):377-82.
26. Peirano G, Pitout JD. Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents. 2010;35(4):316-21.
27. Pitout JD. Enterobacteriaceae that produce extended-spectrum beta-lactamases and AmpC beta-lactamases in the community: the tip of the iceberg? Curr Pharm Des. 2013;19(2):257-63.
28. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589-96.